These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15991152)

  • 21. [Chlamydophila pneumoniae: from its proteomics to arteriosclerosis].
    Villegas E; Sorlózano A; Camacho A; Gutiérrez J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26(10):629-7. PubMed ID: 19100193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis?
    Ustünsoy H; Sivrikoz C; Sirmatel F; Bakir K; Burma O; Kazaz H
    Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):9-13. PubMed ID: 17244915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

  • 26. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
    Aalto-Setälä K; Laitinen K; Erkkilä L; Leinonen M; Jauhiainen M; Ehnholm C; Tamminen M; Puolakkainen M; Penttilä I; Saikku P
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):578-84. PubMed ID: 11304476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?].
    Durkalec J; Hasik J
    Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms other than atherosclerosis in the partnership between chlamydia and stroke.
    Chao CT
    South Med J; 2011 Sep; 104(9):666; author reply 666-7. PubMed ID: 21886090
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chlamydia and arteriosclerosis: a few grey areas still remain].
    Lapetra-Peralta J; Santos-Lozano JM
    Rev Neurol; 2001 Feb 1-15; 32(3):232-3. PubMed ID: 11310275
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic infections and atherosclerosis.
    Kis Z; Burián K; Virók D; Kari G; Endrész V; Gönczöl E
    Acta Microbiol Immunol Hung; 2001; 48(3-4):497-510. PubMed ID: 11791347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
    Muhlestein JB
    Curr Atheroscler Rep; 2000 Jul; 2(4):336-41. PubMed ID: 11122763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of infection in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):671-6. PubMed ID: 15810509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual.
    Vink A; Poppen M; Schoneveld AH; Roholl PJ; de Kleijn DP; Borst C; Pasterkamp G
    Circulation; 2001 Mar; 103(12):1613-7. PubMed ID: 11273986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?
    Mahony JB; Coombes BK
    FEMS Microbiol Lett; 2001 Apr; 197(1):1-9. PubMed ID: 11287138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chlamydia pneumoniae and vascular pathology].
    Maroto Vela MC
    An R Acad Nac Med (Madr); 2000; 117(2):373-86; discussion 387-91. PubMed ID: 11209550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of Chlamydia pneumoniae in the pathogenesis of abdominal aortic aneurysm].
    Witkiewicz W; Gnus JJ; Drohomirecka A
    Pol Merkur Lekarski; 2005 Mar; 18(105):346-50. PubMed ID: 15997650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.